| Sr. No. | Cat No. | Product Description | Pack Size |
|---|---|---|---|
| 1001 | 213-10390-2 | SCF, Recombinant Rat | 10 ug |
| 1002 | 213-10390-AF-1 | SCF, Animal Free, Recombinant Rat | 2 ug |
| 1003 | 213-10390-AF-2 | SCF, Animal Free, Recombinant Rat | 10 ug |
| 1004 | 213-10391-1 | SCGF-α, Recombinant Human | 2 ug |
| 1005 | 213-10391-2 | SCGF-α, Recombinant Human | 10 ug |
| 1006 | 213-10392-1 | SCGF-β, Recombinant Human | 2 ug |
| 1007 | 213-10392-2 | SCGF-β, Recombinant Human | 10 ug |
| 1008 | 213-10393-1 | SDF-1α (CXCL12), Recombinant Human | 2 ug |
| 1009 | 213-10393-2 | SDF-1α (CXCL12), Recombinant Human | 10 ug |
| 1010 | 213-10393-AF-1 | SDF-1 alpha (CXCL12), Animal Free, Recombinant Human | 2 ug |
| 1011 | 213-10393-AF-2 | SDF-1 alpha (CXCL12), Animal Free, Recombinant Human | 10 ug |
| 1012 | 213-10394-1 | SDF-1α (CXCL12), Recombinant Mouse | 2 ug |
| 1013 | 213-10394-2 | SDF-1α (CXCL12), Recombinant Mouse | 10 ug |
| 1014 | 213-10395-1 | SDF-1α (CXCL12), Recombinant Rat | 2 ug |
| 1015 | 213-10395-2 | SDF-1α (CXCL12), Recombinant Rat | 10 ug |
| 1016 | 213-10396-1 | SDF-1β (CXCL12), Recombinant Human | 2 ug |
| 1017 | 213-10396-2 | SDF-1β (CXCL12), Recombinant Human | 10 ug |
| 1018 | 213-10396-AF-1 | SDF-1 beta (CXCL12), Animal Free, Recombinant Human | 2 ug |
| 1019 | 213-10396-AF-2 | SDF-1 beta (CXCL12), Animal Free, Recombinant Human | 10 ug |
| 1020 | 213-10397-1 | SDF-1β (CXCL12), Recombinant Mouse | 2 ug |
| 1021 | 213-10397-2 | SDF-1β (CXCL12), Recombinant Mouse | 10 ug |
| 1022 | 213-10398-1 | SDF-1β (CXCL12), Recombinant Rat | 2 ug |
| 1023 | 213-10398-2 | SDF-1β (CXCL12), Recombinant Rat | 10 ug |
| 1024 | 213-10399-1 | Semaphorin 3A, Recombinant Human | 5 ug |
| 1025 | 213-10399-2 | Semaphorin 3A, Recombinant Human | 25 ug |
| 1026 | 213-10400-1 | SF-20, Recombinant Mouse | 2 ug |
| 1027 | 213-10400-2 | SF-20, Recombinant Mouse | 10 ug |
| 1028 | 213-10401-1 | sFas Ligand, Recombinant Human | 2 ug |
| 1029 | 213-10401-2 | sFas Ligand, Recombinant Human | 10 ug |
| 1030 | 213-10402-1 | sFas Receptor, Recombinant Human | 5 ug |
| 1031 | 213-10402-2 | sFas Receptor, Recombinant Human | 20 ug |
| 1032 | 213-10403-1 | sIL-2Rα, Recombinant Human | 5 ug |
| 1033 | 213-10403-2 | sIL-2Rα, Recombinant Human | 25 ug |
| 1034 | 213-10404-1 | sIL-4Rα, Recombinant Human | 3 ug |
| 1035 | 213-10404-2 | sIL-4Rα, Recombinant Human | 15 ug |
| 1036 | 213-10405-1 | sIL-6Rα, Recombinant Human | 5 ug |
| 1037 | 213-10405-2 | sIL-6Rα, Recombinant Human | 20 ug |
| 1038 | 213-10406-1 | Slit2-N, Recombinant Human | 5 ug |
| 1039 | 213-10406-2 | Slit2-N, Recombinant Human | 25 ug |
| 1040 | 213-10407-1 | Sonic Hedgehog (Shh), Recombinant Human | 5 ug |
| 1041 | 213-10407-2 | Sonic Hedgehog (Shh), Recombinant Human | 25 ug |
| 1042 | 213-10408-1 | Sonic Hedgehog (Shh), Recombinant Mouse | 5 ug |
| 1043 | 213-10408-2 | Sonic Hedgehog (Shh), Recombinant Mouse | 25 ug |
| 1044 | 213-10409-1 | Sox2, Recombinant Human | 5 ug |
| 1045 | 213-10409-2 | Sox2, Recombinant Human | 25 ug |
| 1046 | 213-10410-1 | Sox2-TAT, Recombinant Human | 5 ug |
| 1047 | 213-10410-2 | Sox2-TAT, Recombinant Human | 25 ug |
| 1048 | 213-10411-1 | SPARC/Osteonectin, Recombinant Human | 10 ug |
| 1049 | 213-10411-2 | SPARC/Osteonectin, Recombinant Human | 50 ug |
| 1050 | 213-10412-1 | sRANK Ligand, Recombinant Human | 2 ug |
| 1051 | 213-10412-2 | sRANK Ligand, Recombinant Human | 10 ug |
| 1052 | 213-10413-1 | sRANK Ligand, Recombinant Mouse | 2 ug |
| 1053 | 213-10413-2 | sRANK Ligand, Recombinant Mouse | 10 ug |
| 1054 | 213-10414-1 | sRANK Ligand, Recombinant Rat | 2 ug |
| 1055 | 213-10414-2 | sRANK Ligand, Recombinant Rat | 10 ug |
| 1056 | 213-10415-1 | sRANK Receptor, Recombinant Human | 20 ug |
| 1057 | 213-10415-2 | sRANK Receptor, Recombinant Human | 100 ug |
| 1058 | 213-10416-1 | β-NGF, Recombinant Human | 20 ug |
| 1059 | 213-10416-2 | β-NGF, Recombinant Human | 100 ug |
| 1060 | 213-10416-AF-1 | beta-NGF, Animal Free, Recombinant Human | 20 ug |
| 1061 | 213-10416-AF-2 | beta-NGF, Animal Free, Recombinant Human | 100 ug |
| 1062 | 213-10417-1 | β-NGF, Recombinant Mouse | 5 ug |
| 1063 | 213-10417-2 | β-NGF, Recombinant Mouse | 20 ug |
| 1064 | 213-10418-1 | sTNF Receptor Type I, Recombinant Human | 5 ug |
| 1065 | 213-10418-2 | sTNF Receptor Type I, Recombinant Human | 20 ug |
| 1066 | 213-10419-1 | sTNF Receptor Type II, Recombinant Human | 5 ug |
| 1067 | 213-10419-2 | sTNF Receptor Type II, Recombinant Human | 20 ug |
| 1068 | 213-10420-1 | sTRAIL Receptor-1, Recombinant Human | 10 ug |
| 1069 | 213-10420-2 | sTRAIL Receptor-1, Recombinant Human | 50 ug |
| 1070 | 213-10421-1 | TACI (TNFRSF13B), Recombinant Human | 5 ug |
| 1071 | 213-10421-2 | TACI (TNFRSF13B), Recombinant Human | 20 ug |
| 1072 | 213-10422-1 | TAFA-2, Recombinant Human | 5 ug |
| 1073 | 213-10422-2 | TAFA-2, Recombinant Human | 20 ug |
| 1074 | 213-10423-1 | TARC (CCL17), Recombinant Human | 5 ug |
| 1075 | 213-10423-2 | TARC (CCL17), Recombinant Human | 20 ug |
| 1076 | 213-10424-1 | TECK (CCL25), Recombinant Human | 5 ug |
| 1077 | 213-10424-2 | TECK (CCL25), Recombinant Human | 20 ug |
| 1078 | 213-10425-1 | TFF-1, Recombinant Human | 5 ug |
| 1079 | 213-10425-2 | TFF-1, Recombinant Human | 20 ug |
| 1080 | 213-10426-1 | TFF-2, Recombinant Human | 5 ug |
| 1081 | 213-10426-2 | TFF-2, Recombinant Human | 20 ug |
| 1082 | 213-10427-1 | TFF-3, Recombinant Human | 5 ug |
| 1083 | 213-10427-2 | TFF-3, Recombinant Human | 20 ug |
| 1084 | 213-10428-1 | TGF-α, Recombinant Human | 20 ug |
| 1085 | 213-10428-2 | TGF-α, Recombinant Human | 100 ug |
| 1086 | 213-10428-AF-1 | TGF-alpha, Animal Free, Recombinant Human | 20 ug |
| 1087 | 213-10428-AF-2 | TGF-alpha, Animal Free, Recombinant Human | 100 ug |
| 1088 | 213-10429-1 | TGF-β1 (HEK 293 derived), Recombinant Human | 2 ug |
| 1089 | 213-10429-2 | TGF-β1 (HEK 293 derived), Recombinant Human | 10 ug |
| 1090 | 213-10430-1 | TGF-β1 (CHO cell derived), Recombinant Human | 2 ug |
| 1091 | 213-10430-2 | TGF-β1 (CHO cell derived), Recombinant Human | 10 ug |
| 1092 | 213-10430-AF-1 | TGF-beta1 (CHO cell derived), Animal Free, Recombinant Human | 2 ug |
| 1093 | 213-10430-AF-2 | TGF-beta1 (CHO cell derived), Animal Free, Recombinant Human | 10 ug |
| 1094 | 213-10431-1 | TGF-β2 (insect derived), Recombinant Human | 2 ug |
| 1095 | 213-10431-2 | TGF-β2 (insect derived), Recombinant Human | 10 ug |
| 1096 | 213-10432-1 | TGF-β2 (mammalian derived), Recombinant Human | 2 ug |
| 1097 | 213-10432-2 | TGF-β2 (mammalian derived), Recombinant Human | 10 ug |
| 1098 | 213-10433-1 | TGF-β3 (E.coli derived), Recombinant Human | 2 ug |
| 1099 | 213-10433-2 | TGF-β3 (E.coli derived), Recombinant Human | 10 ug |
| 1100 | 213-10433-AF-1 | TGF-beta3 (E.coli derived), Animal Free, Recombinant Human | 2 ug |
| 1101 | 213-10433-AF-2 | TGF-beta3 (E.coli derived), Animal Free, Recombinant Human | 10 ug |
| 1102 | 213-10434-1 | Thrombomodulin, Recombinant Human | 2 ug |
| 1103 | 213-10434-2 | Thrombomodulin, Recombinant Human | 10 ug |
| 1104 | 213-10435-1 | Thymosin-β4, Recombinant Human | 20 ug |
| 1105 | 213-10435-2 | Thymosin-β4, Recombinant Human | 100 ug |
| 1106 | 213-10436-1 | Tigar, Recombinant Human | 5 ug |
| 1107 | 213-10436-2 | Tigar, Recombinant Human | 25 ug |
| 1108 | 213-10437-1 | TIGAR-TAT, Recombinant Human | 5 ug |
| 1109 | 213-10437-2 | TIGAR-TAT, Recombinant Human | 25 ug |
| 1110 | 213-10438-1 | TIMP-1, Recombinant Human | 2 ug |
| 1111 | 213-10438-2 | TIMP-1, Recombinant Human | 10 ug |
| 1112 | 213-10439-1 | TIMP-2, Recombinant Human | 2 ug |
| 1113 | 213-10439-2 | TIMP-2, Recombinant Human | 10 ug |
| 1114 | 213-10440-1 | TL-1A, Recombinant Human | 5 ug |
| 1115 | 213-10440-2 | TL-1A, Recombinant Human | 20 ug |
| 1116 | 213-10441-1 | TLR-3, Recombinant Human | 5 ug |
| 1117 | 213-10441-2 | TLR-3, Recombinant Human | 25 ug |
| 1118 | 213-10442-1 | TNF-α, Recombinant Human | 10 ug |
| 1119 | 213-10442-2 | TNF-α, Recombinant Human | 50 ug |
| 1120 | 213-10442-AF-1 | TNF-alpha, Animal Free, Recombinant Human | 10 ug |
| 1121 | 213-10442-AF-2 | TNF-alpha, Animal Free, Recombinant Human | 50 ug |
| 1122 | 213-10443-1 | TNF-α, Recombinant Mouse | 5 ug |
| 1123 | 213-10443-2 | TNF-α, Recombinant Mouse | 20 ug |
| 1124 | 213-10444-1 | TNF-α, Recombinant Rat | 5 ug |
| 1125 | 213-10444-2 | TNF-α, Recombinant Rat | 20 ug |
| 1126 | 213-10445-1 | TNF-β (E.coli-derived), Recombinant Human | 5 ug |
| 1127 | 213-10445-2 | TNF-β (E.coli-derived), Recombinant Human | 20 ug |
| 1128 | 213-10446-1 | TPO, Recombinant Human | 2 ug |
| 1129 | 213-10446-2 | TPO, Recombinant Human | 10 ug |
| 1130 | 213-10446-AF-1 | TPO, Animal Free, Recombinant Human | 2 ug |
| 1131 | 213-10446-AF-2 | TPO, Animal Free, Recombinant Human | 10 ug |
| 1132 | 213-10447-1 | TPO, Recombinant Rat | 2 ug |
| 1133 | 213-10447-2 | TPO, Recombinant Rat | 10 ug |
| 1134 | 213-10447-AF-1 | TPO, Animal Free, Recombinant Rat | 2 ug |
| 1135 | 213-10447-AF-2 | TPO, Animal Free, Recombinant Rat | 10 ug |
| 1136 | 213-10448-1 | TPO, Recombinant Mouse | 2 ug |
| 1137 | 213-10448-2 | TPO, Recombinant Mouse | 10 ug |
| 1138 | 213-10448-AF-1 | TPO, Animal Free, Recombinant Mouse | 2 ug |
| 1139 | 213-10448-AF-2 | TPO, Animal Free, Recombinant Mouse | 10 ug |
| 1140 | 213-10449-1 | sTRAIL/Apo2L, Recombinant Human | 10 ug |
| 1141 | 213-10449-2 | sTRAIL/Apo2L, Recombinant Human | 50 ug |
| 1142 | 213-10450-1 | TRAIL, Recombinant Mouse | 10 ug |
| 1143 | 213-10450-2 | TRAIL, Recombinant Mouse | 50 ug |
| 1144 | 213-10451-1 | sTRAIL Receptor-2, Recombinant Human | 10 ug |
| 1145 | 213-10451-2 | sTRAIL Receptor-2, Recombinant Human | 50 ug |
| 1146 | 213-10452-1 | TSG, Recombinant Human | 10 ug |
| 1147 | 213-10452-2 | TSG, Recombinant Human | 50 ug |
| 1148 | 213-10453-1 | TSLP, Recombinant Human | 2 ug |
| 1149 | 213-10453-2 | TSLP, Recombinant Human | 10 ug |
| 1150 | 213-10454-1 | TWEAK, Recombinant Human | 5 ug |
| 1151 | 213-10454-2 | TWEAK, Recombinant Human | 25 ug |
| 1152 | 213-10454-AF-1 | TWEAK, Animal Free, Recombinant Human | 5 ug |
| 1153 | 213-10454-AF-2 | TWEAK, Animal Free, Recombinant Human | 25 ug |
| 1154 | 213-10455-1 | TWEAK Receptor, Recombinant Human | 5 ug |
| 1155 | 213-10455-2 | TWEAK Receptor, Recombinant Human | 25 ug |
| 1156 | 213-10456-1 | Uteroglobin, Recombinant Human | 10 ug |
| 1157 | 213-10456-2 | Uteroglobin, Recombinant Human | 50 ug |
| 1158 | 213-10457-1 | VAP-1, Recombinant Human | 2 ug |
| 1159 | 213-10457-2 | VAP-1, Recombinant Human | 10 ug |
| 1160 | 213-10458-1 | Vaspin, Recombinant Human | 5 ug |
| 1161 | 213-10458-2 | Vaspin, Recombinant Human | 25 ug |
| 1162 | 213-10459-1 | VCAM-1, Recombinant Human | 10 ug |
| 1163 | 213-10459-2 | VCAM-1, Recombinant Human | 50 ug |
| 1164 | 213-10460-1 | VEGF, Recombinant Mouse | 2 ug |
| 1165 | 213-10460-2 | VEGF, Recombinant Mouse | 10 ug |
| 1166 | 213-10460-AF-1 | VEGF, Animal Free, Recombinant Mouse | 2 ug |
| 1167 | 213-10460-AF-2 | VEGF, Animal Free, Recombinant Mouse | 10 ug |
| 1168 | 213-10461-1 | VEGF, Recombinant Rat | 2 ug |
| 1169 | 213-10461-2 | VEGF, Recombinant Rat | 10 ug |
| 1170 | 213-10462-1 | VEGF<sub>121</sub>, Recombinant Human | 2 ug |
| 1171 | 213-10462-2 | VEGF<sub>121</sub>, Recombinant Human | 10 ug |
| 1172 | 213-10462-AF-1 | VEGF (121), Animal Free, Recombinant Human | 2 ug |
| 1173 | 213-10462-AF-2 | VEGF (121), Animal Free, Recombinant Human | 10 ug |
| 1174 | 213-10463-1 | VEGF<sub>165</sub>, Recombinant Human | 2 ug |
| 1175 | 213-10463-2 | VEGF<sub>165</sub>, Recombinant Human | 10 ug |
| 1176 | 213-10463-AF-1 | VEGF (165), Animal Free, Recombinant Human | 2 ug |
| 1177 | 213-10463-AF-2 | VEGF (165), Animal Free, Recombinant Human | 10 ug |
| 1178 | 213-10464-1 | VEGF-B, Recombinant Human | 5 ug |
| 1179 | 213-10464-2 | VEGF-B, Recombinant Human | 20 ug |
| 1180 | 213-10465-1 | VEGF-C, Recombinant Human | 5 ug |
| 1181 | 213-10465-2 | VEGF-C, Recombinant Human | 20 ug |
| 1182 | 213-10466-1 | Vimentin, Recombinant Human | 20 ug |
| 1183 | 213-10466-2 | Vimentin, Recombinant Human | 100 ug |
| 1184 | 213-10467-1 | VEGF-D, Recombinant Human | 2 ug |
| 1185 | 213-10467-2 | VEGF-D, Recombinant Human | 10 ug |
| 1186 | 213-10468-1 | Visfatin, Recombinant Human | 5 ug |
| 1187 | 213-10468-2 | Visfatin, Recombinant Human | 25 ug |
| 1188 | 213-10469-1 | Vitronectin, Recombinant Human | 100 ug |
| 1189 | 213-10469-2 | Vitronectin, Recombinant Human | 500 ug |
| 1190 | 213-10469-AF-1 | Vitronectin, Animal Free, Recombinant Human | 100 ug |
| 1191 | 213-10469-AF-2 | Vitronectin, Animal Free, Recombinant Human | 500 ug |
| 1192 | 213-10470-1 | WISP-1, Recombinant Human | 5 ug |
| 1193 | 213-10470-2 | WISP-1, Recombinant Human | 20 ug |
| 1194 | 213-10471-1 | WISP-3, Recombinant Human | 5 ug |
| 1195 | 213-10471-2 | WISP-3, Recombinant Human | 20 ug |
| 1196 | 213-10472-1 | WNT-1, Recombinant Human | 2 ug |
| 1197 | 213-10472-2 | WNT-1, Recombinant Human | 10 ug |
| 1198 | 213-10473-1 | WNT-7A, Recombinant Human | 3 ug |
| 1199 | 213-10473-2 | WNT-7A, Recombinant Human | 15 ug |
| 1200 | 213-10474-1 | IL-12 p40, Recombinant Human | 2 ug |
| 1201 | 213-10474-2 | IL-12 p40, Recombinant Human | 10 ug |
| 1202 | 214-10002 | Delta Opioid Receptor 3-17 Blocking Peptide | 100 ug |
| 1203 | 214-10003 | ASIC Beta blocking peptide | 20 ug |
| 1204 | 214-10004 | Alpha 2c Adrenergic Receptor blocking peptide | 50 ul |
| 1205 | 214-10005 | CD39, control peptide | 20 ug |
| 1206 | 214-10006 | Mu Opioid Receptor Blocking Peptide | 50 ul |
| 1207 | 214-10007 | Delta Opioid Receptor 358-372 Blocking Peptide | 20 ug |
| 1208 | 214-10008 | OrphaninFQ/Nociceptin Blocking Peptide | 50 ul |
| 1209 | 214-10009 | P2X3 Peptide | 50 ul |
| 1210 | 214-10010 | P2X2 Blocking Peptide | 100 ug |
| 1211 | 214-10011 | proDynorphin(rat) Peptide | 100 ug |
| 1212 | 214-10012 | OrphaninFQ/Nociceptin Blocking Peptide | 50 ul |
| 1213 | 214-10013 | P2X1 Blocking Peptide | 20 ug |
| 1214 | 214-10014 | proDynorphin (guinea pig) Blocking Peptide | 20 ug |
| 1215 | 214-10015 | proDynorphin (rat) Peptide | 100 ul |
| 1216 | 214-10016 | Endomorphin 2 | 20 ug |
| 1217 | 214-10017 | PGP9.5 175-191 Blocking Peptide | 20 ug |
| 1218 | 214-10018 | P2Y2 Peptide | 50 ul |
| 1219 | 214-10019 | ppNPY Peptide | 20 ul |
| 1220 | 214-10020 | mGluR2/3, control peptide | 100 ug |
| 1221 | 214-10021 | NTS1 Blocking Peptide | 100 ug |
| 1222 | 214-10022 | VR1 C Blocking Peptide | 100 ug |
| 1223 | 214-10023 | Substance P blocking peptide | 50 ul |
| 1224 | 214-10024 | LepRb/OBRb | 50 ul |
| 1225 | 214-10025 | Alpha 2a Adrenergic Receptor blocking peptide | 50 ul |
| 1226 | 214-10027 | NPY Y2 | 50 ul |
| 1227 | 214-10028 | TRPV1 Mouse Specific | 100 ug |
| 1228 | 214-10029 | ORL-1 Peptide | 100 ul |
| 1229 | 214-10031 | Olig1 Peptide | 100 ul |
| 1230 | 214-20001 | mGluR6 Blocking Peptide | 50 ul |
| 1231 | 227-10001 | Rubella Virus Grade III Antigen | 1 ml |
| 1232 | 227-10002 | Rubella Virus Grade IV Antigen | 1 mg |
| 1233 | 227-10004 | Rubella Grade Iv Antigen W/PBS | 1 mg |
| 1234 | 227-10005 | RSVP Antigen | 1 mg |
| 1235 | 227-10007 | VZV/PBS Antigen | 1 ml |
| 1236 | 227-10008 | VZV Antigen | 1 ml |
| 1237 | 227-10009 | HSV-1 Antigen | 1 ml |
| 1238 | 227-10010 | HSV-1 Concentrate Antigen | 1 ml |
| 1239 | 227-10011 | EBV Antigen | 1 ml |
| 1240 | 227-10012 | CMV-G Antigen | 1 ml |
| 1241 | 227-10013 | CMV Grade III Antigen | 1 mg |
| 1242 | 227-10014 | CMV-M Concentrate Antigen | 1 ml |
| 1243 | 227-10015 | CMV Ext 2 (KLC) Concentrate | 1 ml |
| 1244 | 227-10016 | Rubeola Antigen | 1 ml |
| 1245 | 227-10017 | HSV-2 Antigen | 1 ml |
| 1246 | 227-10018 | VZV Grade II Antigen | 1 ml |
| 1247 | 227-10019 | HSV-2 Inactivated Concentrate | 1 ml |
| 1248 | 227-10020 | Rotavirus SA-11 Antigen | 1 ml |
| 1249 | 227-10021 | Mumps Antigen | 1 ml |
| 1250 | 227-10023 | RSV Antigen | 1 ml |
| 1251 | 227-10025 | Hepatitis A Antigen | 1 ml |
| 1252 | 227-10026 | HAV Grade II Concentrate | 1 ml |
| 1253 | 227-10028 | Human Apolipoprotein AI | 1 mg |
| 1254 | 227-10029 | PSA ACT Complex | 25 ug |
| 1255 | 227-10030 | Prostate Specific Antigen | 100 ug |
| 1256 | 227-10031 | SNAP-25 (a.a. 183-197) | 500 ug |
| 1257 | 227-10034 | Bovine Gamma Globulin | 100 gram |
| 1258 | 227-10035 | Human CRP, Recombinant | 1 mg |
| 1259 | 227-10036 | Human MCP-1, Recombinant | 20 ug |
| 1260 | 227-10037 | Human IGFBP-1 | 100 ug |
| 1261 | 227-10038 | SS-B (La) Antigen, Recombinant | 100 ug |
| 1262 | 227-10039 | Cystatin C, Recombinant | 1 mg |
| 1263 | 227-10040 | Human Cystatin C | 1 mg |
| 1264 | 227-10041 | Human Adiponectin | 100 ug |
| 1265 | 227-10042 | Human NT-proBNP, Recombinant | 100 ug |
| 1266 | 227-10043 | Human CA50 Calibrator Grade | 50 KU |
| 1267 | 227-10044 | Human CA242 Calibrator Grade | 50 KU |
| 1268 | 227-10045 | Human Myeloma IgE, kappa | 1 ml |
| 1269 | 227-10046 | Intrinsic Factor, Pig | 100 ug |
| 1270 | 227-10047 | Rheumatoid Factor Ctrl (Plasma | 1 ml |
| 1271 | 227-10049 | Human Hemoglobin A1c (HbA1c) | 1 mg |
| 1272 | 227-10051 | Prostatic Acid Phosphatase | 1 mg |
| 1273 | 227-10052 | hCG Beta >= 98% Pure | 100 ug |
| 1274 | 227-10053 | hCG Alpha >= 98% Pure | 100 ug |
| 1275 | 227-10054 | hCG >65% Pure | 1 mg |
| 1276 | 227-10055 | FSH >98% Pure | 5 KU |
| 1277 | 227-10070 | Chicken IgY | 50 mg |
| 1278 | 227-10071 | hGH, Recombinant | 100 ug |
| 1279 | 227-10072 | Human TPO, Recombinant | 100 ug |
| 1280 | 227-10073 | Angiotensin | 1 mg |
| 1281 | 227-10074 | Testosterone-3-BSA | 1 mg |
| 1282 | 227-10075 | hCG, USP Grade | 5 mg |
| 1283 | 227-10080 | NSE, Recombinant | 100 ug |
| 1284 | 227-10081 | tTG, Recombinant | 100 ug |
| 1285 | 227-10083 | Chicken IgY | 10 ml |
| 1286 | 227-10084 | Human Procalcitonin, Recombinant | 100 ug |
| 1287 | 227-10085 | Human PSA > 95% Pure | 100 ug |
| 1288 | 227-10086 | Human FSH > 95% Pure | 1 mg |
| 1289 | 227-10089 | Mitochondrial Antigen | 1000 UNITS |
| 1290 | 227-10091 | Human IgD | 25 ug |
| 1291 | 227-10092 | CENPB, Human Recombinant | 1 mg |
| 1292 | 227-10093 | hCG Beta >=98% Pure | 100 ug |
| 1293 | 227-10094 | hCG Alpha >=98% Pure | 100 ug |
| 1294 | 227-10095 | hCG >=98% Pure | 100 ug |
| 1295 | 227-10096 | hCG >=50% Pure | 1 mg |
| 1296 | 227-10102 | Human Myoglobin, Recombinant | 1 mg |
| 1297 | 227-10103 | Pig Pancreas Alpha Amylase | 25 KU |
| 1298 | 227-10105 | Human Osteopontin | 100 ug |
| 1299 | 227-10109 | Myeloperoxidase B (MPO B) | 100 ug |
| 1300 | 227-10115 | Human Liver Ferritin | 1 mg |
| 1301 | 227-10116 | Human Placenta Ferritin | 1 mg |
| 1302 | 227-10118 | Lactate Dehydrogenase Total | 100 UNITS |
| 1303 | 227-10120 | Human AFP Antigen Grade | 1 mg |
| 1304 | 227-10121 | Human AFP Antigen Grade | 1 mg |
| 1305 | 227-10122 | Human D-Dimer | 1 mg |
| 1306 | 227-10123 | ENA Extract | 0.25 ml |
| 1307 | 227-10131 | Human NPR-C (a.a 199-212) Peptide | 1 mg |
| 1308 | 227-10133 | Human NPR-B (a.a. 288-302) Peptide | 1 mg |
| 1309 | 227-10135 | Beta-Defensin-1(aa1-36) Peptide | 100 ug |
| 1310 | 227-10136 | Human pro-BNP (1-108) Recombinant | 10 ug |
| 1311 | 227-10138 | Human proBNP, N-terminal | 10 ug |
| 1312 | 227-10139 | Human Pro-BNP, C-terminal | 100 ug |
| 1313 | 227-10143 | Presenilin-1 N-Terminal Peptide | 1 mg |
| 1314 | 227-10148 | Mouse Myeloma IgG1,k (MOPC 21) | 1 mg |
| 1315 | 227-10149 | Jo-1 Antigen, Recombinant | 100 ug |
| 1316 | 227-10150 | Human Myoglobin Antigen | 1 mg |
| 1317 | 227-10151 | Troponin I-cardiac >98% Pure | 100 ug |
| 1318 | 227-10152 | Human Liver Ferritin | 1 mg |
| 1319 | 227-10153 | hCG | 100 ug |
| 1320 | 227-10154 | Proteinase 3 Antigen (cANCA) | 200 ug |
| 1321 | 227-10155 | Jo-1 Antigen | 200 ug |
| 1322 | 227-10156 | Rat IL-6, Recombinant | 10 ug |
| 1323 | 227-10158 | Rat TNF-a, Recombinant | 20 ug |
| 1324 | 227-10162 | Human IGF-I, Recombinant | 100 ug |
| 1325 | 227-10163 | Human Epidermal Growth Factor | 500 ug |
| 1326 | 227-10164 | Human FGF-acidic, Recombinant | 50 ug |
| 1327 | 227-10165 | Human FGF-Basic, Recombinant | 50 ug |
| 1328 | 227-10166 | Mouse IL-6, Recombinant | 10 ug |
| 1329 | 227-10167 | Human IL-1a, Recombinant | 10 ug |
| 1330 | 227-10168 | Human IL-2, Recombinant | 50 ug |
| 1331 | 227-10169 | Human IL-3, Recombinant | 10 ug |
| 1332 | 227-10170 | Human IL-4, Recombinant | 20 ug |
| 1333 | 227-10172 | Human IL-8 (1-77) Recombinant | 25 ug |
| 1334 | 227-10174 | Human IL-8 (1-72) Recombinant | 25 ug |
| 1335 | 227-10175 | Human TNF-alpha, Recombinant | 50 ug |
| 1336 | 227-10177 | Human GM-CSF, Recombinant | 20 ug |
| 1337 | 227-10178 | Human TNF-beta, Recombinant | 20 ug |
| 1338 | 227-10179 | Human IP-10 (CXCL10) Recombinant | 25 ug |
| 1339 | 227-10180 | Human Leptin, Recombinant | 1 mg |
| 1340 | 227-10195 | Human Plasma Transferrin | 100 mg |
| 1341 | 227-10196 | Human Myeloma IgA1 Lambda | 5 mg |
| 1342 | 227-10197 | Human Myeloma IgA1, Kappa | 5 mg |
| 1343 | 227-10200 | Human Neutrophil Lysozyme | 1 mg |
| 1344 | 227-10201 | Human Myeloma IgG1, kappa | 1 mg |
| 1345 | 227-10204 | Human Myeloma IgA2 kappa | 1 mg |
| 1346 | 227-10206 | Lp(a) Calibrator 3 | 5 ml |
| 1347 | 227-10207 | Mouse PAI-1, Recombinant | 500 ug |
| 1348 | 227-10208 | Human Vitronectin | 100 ug |
| 1349 | 227-10209 | Rat IgG | 1 Gram |
| 1350 | 227-10210 | BSA, Standard Powder | 50 gramS |
| 1351 | 227-10211 | Rabbit IgG – Differential PPT | 1 Gram |
| 1352 | 227-10212 | Rabbit IgG – Differential PPT | 1 Gram |
| 1353 | 227-10213 | Mouse IgG Protein A 22-28mg/ml | 20 mg |
| 1354 | 227-10214 | Mouse Igg protein A 50-55 mg/m | 20 mg |
| 1355 | 227-10216 | Mouse IgG (9-13MG/ML) | 20 mg |
| 1356 | 227-10217 | Mouse IgG (CA Cut)(10-20mg/ml) | 20 mg |
| 1357 | 227-10219 | Goat Igg – Differential ppt | 1 Gram |
| 1358 | 227-10220 | Sheep IgG, >70mg/ml | 50 mg |
| 1359 | 227-10221 | Sheep IgG-CA/SS, 45-55mg/ml | 20 mg |
| 1360 | 227-10222 | Sheep IgG, Protein A | 10 mg |
| 1361 | 227-10224 | EGFR pTyr 1173 Peptide | 100 ug |
| 1362 | 227-10225 | Human TSH >95% Pure | 50 ug |
| 1363 | 227-10226 | Human Myeloma IgE | 100 ug |
| 1364 | 227-10227 | Human Growth Hormone > = 70% Pure | 1 mg |
| 1365 | 227-10228 | Estriol-6 | 1 ml |
| 1366 | 227-10229 | Progesterone 3-HRP Conjugate | 1 ml |
| 1367 | 227-10230 | Rat Troponin T-Cardiac | 100 ug |
| 1368 | 227-10231 | Human CA125 Calibrator Grade | 50 KU |
| 1369 | 227-10232 | Human Brain S-100b Protein | 1 mg |
| 1370 | 227-10233 | Troponin T-Cardiac > 98% Pure | 500 ug |
| 1371 | 227-10234 | Troponin T- Skeletal >95% Pure | 500 ug |
| 1372 | 227-10235 | Purified Human Myoglobin | 1 mg |
| 1373 | 227-10236 | Human Thyroglobulin | 1 mg |
| 1374 | 227-10237 | Myelin Basic Protein | 1 mg |
| 1375 | 227-10240 | Beta-Galactosidase | 100 ug |
| 1376 | 227-10241 | Complement C1q | 1 mg |
| 1377 | 227-10242 | CRP Antigen Grade | 5 mg |
| 1378 | 227-10274 | CMV II Antigen | 1 mg |
| 1379 | 227-10275 | HSVgG 2 Native Antigen | 0.5 ml |
| 1380 | 227-10284 | Influezna B Soluble Antigen | 1 ml |
| 1381 | 227-10287 | CK-BB | 100 ug |
| 1382 | 227-10288 | FSH 98% PURE | 100 ug |
| 1383 | 227-10290 | Human TSH 98% Pure | 100 ug |
| 1384 | 227-10291 | Human THYROGLOBULIN ANTIGEN | 1 mg |
| 1385 | 227-10293 | Myoglobin-Free Serum | 50 ml |
| 1386 | 227-10294 | CRP Free Serum | 50 ml |
| 1387 | 227-10297 | Chagas Multiantigen, Recombinant | 500 ug |
| 1388 | 227-10299 | C. botulinum Toxin A Peptide | 500 ug |
| 1389 | 227-10301 | Hepatitis B ‘e’ Ag, Recombinant | 1 mg |
| 1390 | 227-10312 | HPV16 L1 Protein, Recombinant | 100 ug |
| 1391 | 227-10313 | HPV18 L1 Protein, Recombinant | 100 ug |
| 1392 | 227-10315 | Dengue 2, Envelope, Recombinant | 100 ug |
| 1393 | 227-10316 | Dengue Type 2 NS1, Recombinant | 100 ug |
| 1394 | 227-10317 | HTLV-I gp21 Recombinant | 100 ug |
| 1395 | 227-10318 | HTLV-I gp46 Recombinant | 100 ug |
| 1396 | 227-10319 | Japanese Encephalitis, Recombinant | 100 ug |
| 1397 | 227-10320 | Chagas Antigen 1F8, Recombinant | 500 ug |
| 1398 | 227-10321 | Hepatitis B Surface Ag (ad) | 1 mg |
| 1399 | 227-10323 | Plasmodium vivax MSP-1, Recombinant | 1 mg |
| 1400 | 227-10324 | Plasmodium vivax CSP, Recombinant | 1 mg |
| 1401 | 227-10325 | HIV-1 gp41 Ag, Type O, Recombinant | 100 ug |
| 1402 | 227-10326 | M. tuberculosis, 38kDa, Recombinant | 100 ug |
| 1403 | 227-10327 | P. falciparum HRP-2, Recombinant | 1 mg |
| 1404 | 227-10328 | HIV-1 Integrase p31, Recombinant | 100 ug |
| 1405 | 227-10330 | Rubella Virus E1 Mosaic Recombinant | 1 mg |
| 1406 | 227-10331 | Rubella Virus E2 Recombinant | 1 mg |
| 1407 | 227-10332 | Mycoplasma pneumoniae | 1 mg |
| 1408 | 227-10334 | T. pallidum p17 Ag Recombinant | 1 mg |
| 1409 | 227-10340 | Hepatitis B Surface Ag (ad) | 1 mg |
| 1410 | 227-10344 | Leishmania donovani, Recombinant | 1 mg |
| 1411 | 227-10345 | C. albicans Enolase, Recombinant | 1 mg |
| 1412 | 227-10348 | Coxsackie B1 (Tucson), Recombinant | 1 mg |
| 1413 | 227-10349 | HCV NS3, Genotype 1a, Recombinant | 1 mg |
| 1414 | 227-10352 | Borrelia garinii, Recombinant | 1 mg |
| 1415 | 227-10353 | EBV EBNA-1, Recombinant | 1 mg |
| 1416 | 227-10354 | B.BURGDORFERI VlsE, Recombinant | 1 mg |
| 1417 | 227-10355 | CMV Ag pp72 (UL123) Recombinant | 1 mg |
| 1418 | 227-10356 | EBV p138 (EA-D) Recombinant | 1 mg |
| 1419 | 227-10357 | B. burgdorferi Recombinant | 1 mg |
| 1420 | 227-10359 | T. pallidum p17 Ag, Recombinant | 1 mg |
| 1421 | 227-10360 | T. pallidum p41 Recombinant | 1 mg |
| 1422 | 227-10361 | T. pallidum Tmp Ag Recombinant | 1 mg |
| 1423 | 227-10362 | T. pallidum p15 Ag Recombinant | 1 mg |
| 1424 | 227-10363 | HIV-1 gp160, Recombinant | 1 mg |
| 1425 | 227-10367 | Aflatoxin, BSA Conjugated | 1 mg |
| 1426 | 227-10368 | Varicella Zoster Virus Antigen | 1 mg |
| 1427 | 227-10369 | VZV Glycoprotein Antigen (Ellen) | 1 mg |
| 1428 | 227-10370 | Helicobacter pylori Antigen | 1 mg |
| 1429 | 227-10371 | Rubeola (Measles) Antigen | 1 mg |
| 1430 | 227-10374 | Aspergillus fumigatus | 1 mg |
| 1431 | 227-10375 | Borrelia afzelii | 1 mg |
| 1432 | 227-10376 | Coxsackievirus B1 Antigen | 1 mg |
| 1433 | 227-10377 | Coxsackievirus B6 Antigen | 1 mg |
| 1434 | 227-10378 | Coxsackievirus B5 Antigen | 1 mg |
| 1435 | 227-10381 | Legionella pneumophila Antigen | 1 mg |
| 1436 | 227-10383 | Candida albicans Antigen (Wild) | 1 mg |
| 1437 | 227-10384 | Mycoplasma pneumoniae Ag (FH) | 1 mg |
| 1438 | 227-10386 | Campylobacter jejuni Antigen | 1 mg |
| 1439 | 227-10387 | T. PALLIDUM P41 Recombinant | 1 mg |
| 1440 | 227-10389 | HTLV-I Envelope Ag Recombinant | 1 mg |
| 1441 | 227-10390 | HTLV-I p24 Antigen Recombinant | 1 mg |
| 1442 | 227-10391 | T. pallidum p17 Ag Recombinant | 1 mg |
| 1443 | 227-10392 | HIV-2 gp36 seq | 1 mg |
| 1444 | 227-10393 | HIV-1 p24 Ag Recombinant | 1 mg |
| 1445 | 227-10395 | SARS-CoV, Nucl. (340-390) Recombinant | 1 mg |
| 1446 | 227-10396 | SARS-CoV, Nucleocapsid, Recombinant | 1 mg |
| 1447 | 227-10397 | SARS-CoV, E Protein, Recombinant | 1 mg |
| 1448 | 227-10398 | SARS-CoV, Spike (Middle) Recombinant | 1 mg |
| 1449 | 227-10399 | SARS-CoV, Spike (C-term) Recombinant | 1 mg |
| 1450 | 227-10400 | EBV (HHV-4) EA-D Recombinant | 1 mg |
| 1451 | 227-10401 | T. pallidum p41 Ag, Recombinant | 1 mg |
| 1452 | 227-10403 | RSV, Long Strain | 1 mg |
| 1453 | 227-10414 | Parainfluenza 3 Strain III | 1 mg |
| 1454 | 227-10415 | Parainfluenza 1 Strain Sendai | 1 mg |
| 1455 | 227-10427 | HSV-1 gG, Recombinant | 1 mg |
| 1456 | 227-10428 | HSV-2 gG2 Recombinant | 1 mg |
| 1457 | 227-10439 | Protein A, Recombinant | 1 Gram |
| 1458 | 227-20009 | Treponema pallidum Ag | 1 mg |
| 1459 | 227-20010 | Rubella Antigen (igG/IgM) | 1 mg |
| 1460 | 227-20011 | Human Seminal Plasma | 10 ml |
| 1461 | 227-20012 | Streptolysin O, Recombinant | 1 mg |
| 1462 | 227-20013 | Human IgG3, Polyclonal | 1 mg |
| 1463 | 227-20014 | 1,25-Dihydroxy Vitamin D3 | 10 ug |
| 1464 | 227-20017 | LP-PLA2 Recombinant | 10 ug |
| 1465 | 227-20040 | KIM-1 Recombinant | 50 ug |
| 1466 | 227-20044 | CA19-9 Calibrator Grade | 50 KU |
| 1467 | 227-20045 | CA19-9 Calibrator Grade | 50 KU |
| 1468 | 227-20046 | CA72-4 | 50 KU |
| 1469 | 227-20047 | Chicken IgY | 1 Gram |
| 1470 | 227-20049 | D-Dimer | 1 mg |
| 1471 | 227-20050 | Human Placenta Ferritin | 1 mg |
| 1472 | 227-20051 | Human Epididymis Protein 4 | 0.025 MG |
| 1473 | 227-20054 | Human Epididymis Protein 4 | 50 PMOL |
| 1474 | 227-20055 | Complement C1q | 1 mg |
| 1475 | 227-20056 | Calprotectin | 200 ug |
| 1476 | 227-20057 | GBM Antigen | 200 ug |
| 1477 | 227-20058 | Histone Antigen | 1 mg |
| 1478 | 227-20059 | Mitochondrial Antigen | 200 ug |
| 1479 | 227-20060 | Nucleosome Antigen | 1 mg |
| 1480 | 227-20061 | Ribosomal P Antigen | 200 ug |
| 1481 | 227-20062 | BPI Protein | 200 ug |
| 1482 | 227-20063 | Cathepsin G | 1 mg |
| 1483 | 227-20064 | Prothrombin | 1 mg |
| 1484 | 227-20065 | Annexin A3 | 200 ug |
| 1485 | 227-20066 | Elastase | 1 mg |
| 1486 | 227-20067 | Human Epididymis Protein 4 | 50 PMOL |
| 1487 | 227-20068 | Purified Mouse IgM Kappa | 1 mg |
| 1488 | 227-20075 | Mouse IGG (AZIDE FREE) | 20 mg |
| 1489 | 227-20077 | Purified Bovine Osteocalcin | 100 ug |
| 1490 | 227-20078 | CMV-gB ANTIGEN | 1 mg |
| 1491 | 227-20079 | Recombinant MV-N (RUBEOLA) | 1 mg |
| 1492 | 227-20080 | Mumps Grade III Antigen | 1 mg |
| 1493 | 227-20083 | Human TPO, Recombinant | 100 ug |
| 1494 | 227-20085 | IgM Mouse Isotypic Control | 200 ug |
| 1495 | 227-20086 | HIV-1 gp120 (v3 loop), Recombinant | 1 mg |
| 1496 | 227-20087 | Influenza A H1 (Swine) Peptide | 50 ug |
| 1497 | 227-20088 | Influenza A N1 (Swine) Peptide | 1 mg |
| 1498 | 227-20089 | Influenza A H1 Peptide | 50 ug |
| 1499 | 227-20091 | Influenza A H1 Peptide | 50 ug |
| 1500 | 227-20093 | Influenza A N1 Peptide | 50 ug |
| 1501 | 227-20094 | Hepatitis B Surface Ag (ay) | 1 mg |
| 1502 | 227-20096 | B. afzelii Osp-C Recombinant | 1 mg |
| 1503 | 227-20097 | Trypanosoma cruzi TcF Recombinant | 1 mg |
| 1504 | 227-20098 | Trypanosoma cruzi TcFr2 Recombinant | 1 mg |
| 1505 | 227-20101 | HIV-1&2 gp41/gp36 recombinant | 2 mg |
| 1506 | 227-20104 | Chikungunya W.T. gp E1 Recombinant | 100 ug |
| 1507 | 227-20106 | Dengue Type 1 NS1 Recombinant | 100 ug |
| 1508 | 227-20107 | Dengue Type 2 NS1 Recombinant | 100 ug |
| 1509 | 227-20108 | Dengue Type 3 NS1 Recombinant | 100 ug |
| 1510 | 227-20109 | Dengue Type 4 NS1 Recombinant | 100 ug |
| 1511 | 227-20110 | Dengue Type 1 E.P. Recombinant | 100 ug |
| 1512 | 227-20111 | Dengue Type 2 E.P. Recombinant | 100 ug |
| 1513 | 227-20112 | Dengue Type 3 E.P. Recombinant | 100 ug |
| 1514 | 227-20113 | Dengue Type 4 E.P. Recombinant | 100 ug |
| 1515 | 227-20115 | CMV pp52(ul44 Recombinant | 500 ug |
| 1516 | 227-20116 | CMV pp52 (UL 44) Recombinant | 0.1 ml |
| 1517 | 227-20117 | CMV pp65(ul83) Recombinant | 500 ug |
| 1518 | 227-20118 | CMV pp150 (UL32) Recombinant | 500 ug |
| 1519 | 227-20119 | CMV pp 150 (UL 32) Recombinant | 0.1 ml |
| 1520 | 227-20120 | CMV pp 150 (UL32) Recombinant | 1 mg |
| 1521 | 227-20121 | CMV pp 52 (UL44) Recombinant | 1 mg |
| 1522 | 227-20122 | CMV pp 65 (UL83) Recombinant | 1 mg |
| 1523 | 227-20123 | CMV pp 38 (UL80a) Recombinant | 1 mg |
| 1524 | 227-20124 | T. pallidum p47 Recombinant | 1 mg |
| 1525 | 227-20125 | Salmonella typhi pagC Recombinant | 1 mg |
| 1526 | 227-20126 | EBV VCA p23 Recombinant | 1 mg |
| 1527 | 227-20127 | EBV VCA p 18 Recombinant | 1 mg |
| 1528 | 227-20129 | Toxo gondii SAG1 (p30) Recombinant | 1 mg |
| 1529 | 227-20130 | Leishmania chagasi, Recombinant | 1 mg |
| 1530 | 227-20131 | EBV p54 (EA-D) Recombinant | 1 mg |
| 1531 | 227-20132 | B. afzelii Osp-C Recombinant | 1 mg |
| 1532 | 227-20133 | Ebola Sudan NP Recombinant | 1 mg |
| 1533 | 227-20134 | Ebola Zaire NP Recombinant | 1 mg |
| 1534 | 227-20135 | HB pre-S1+S2 | 1 mg |
| 1535 | 227-20136 | HB Pre-S2 | 1 mg |
| 1536 | 227-20137 | Toxo gondii p35 (GRA8), Recombinant | 1 mg |
| 1537 | 227-20138 | T. pallidum p15 Recombinant | 1 mg |
| 1538 | 227-20139 | T. pallidum p17 Recombinant | 1 mg |
| 1539 | 227-20141 | Trypanosoma cruzi (Chagas) 1F8 | 1 mg |
| 1540 | 227-20143 | Trypanosoma cruzi (Chagas) FRA | 1 mg |
| 1541 | 227-20144 | M. tuberculosis CFP10, Recombinant | 100 ug |
| 1542 | 227-20145 | Dengue Type 4, NS1, Recombinant | 1 mg |
| 1543 | 227-20147 | HIV-1 Ag, Recombinant | 1 mg |
| 1544 | 227-20148 | HSV-2 gG | 1 mg |
| 1545 | 227-20149 | P.falciparum pAldolase, Recombinant | 1 mg |
| 1546 | 227-20150 | HRP-2, Recombinant | 1 mg |
| 1547 | 227-20151 | P.falciparum pLDH, Recombinant | 1 mg |
| 1548 | 227-20152 | p. VIVAX Pldh, Recombinant | 1 mg |
| 1549 | 227-20153 | HCV NS3/Core/NS4/NS5 Recombinant | 1 mg |
| 1550 | 227-20154 | HCV NS3/Core/NS4/NS5 Recombinant | 1 mg |
| 1551 | 227-20155 | P.Vivax MSP-1 Recombinant | 1 mg |
| 1552 | 227-20156 | P.Vivax MSP-1 Recombinant | 1 mg |
| 1553 | 227-20157 | P.falciparum MSP-1 Recombinant | 1 mg |
| 1554 | 227-20158 | P.falciparum MSP-1 Recombinant | 1 mg |
| 1555 | 227-20159 | HER2/Erb82 Recombinant | 1 mg |
| 1556 | 227-20160 | T.Pallidum p47 Recombinant | 1 mg |
| 1557 | 227-20161 | B. afzelii VlsE Recombinant | 1 mg |
| 1558 | 227-20162 | B. garinii VlsE Recombinant | 1 mg |
| 1559 | 227-20163 | Pro-BNP Recombinant | 1 mg |
| 1560 | 227-20164 | Interleukin 18 (IL-18) Recombinant | 1 mg |
| 1561 | 227-20165 | Human NT-Pro-BNP Recombinant | 1 mg |
| 1562 | 227-20166 | FABP3, Recombinant | 1 mg |
| 1563 | 227-20167 | Amyloid A, Serum (SAA) Recombinant | 1 mg |
| 1564 | 227-20168 | Troponin I – Cardiac Recombinant | 1 mg |
| 1565 | 227-20169 | Influenza A (H3N2) Antigen | 1 ml |
| 1566 | 227-20170 | Ferritin Light Chain Recombinant | 1 mg |
| 1567 | 227-20171 | HIV Chimeric Recombinant | 1 mg |
| 1568 | 227-20172 | HIV Chimeric Recombinant | 1 mg |
| 1569 | 227-20173 | HIV-1 p24 Recombinant | 500 ug |
| 1570 | 227-20174 | HIV Chimeric Recombinant | 1 mg |
| 1571 | 227-20175 | HIV Chimeric Recombinant | 1 mg |
| 1572 | 227-20176 | T.Pallidum TmpA Recombinant | 100 ug |
| 1573 | 227-20177 | HIV-1 gp 41 Recombinant | 1 mg |
| 1574 | 227-20178 | HIV-2 gp 36 Recombinant | 1 mg |
| 1575 | 227-20179 | Zika Virus Envelope Recombinant | 1 mg |
| 1576 | 227-20180 | Zika Virus NS1 Recombinant | 1 mg |
| 1577 | 227-20181 | Parvovirus B19 NS1, Recombinant | 1 mg |
| 1578 | 227-20182 | Parvovirus B19 VP1, Recombinant | 1 mg |
| 1579 | 227-20183 | Parvovirus B19 VP2 VLPs, Recombinant | 1 mg |
| 1580 | 227-20184 | Parvovirus B19 VP1, Recombinant | 1 mg |
| 1581 | 227-20185 | Parvovirus B19 VP1/2, Recombinant | 1 mg |
| 1582 | 227-20186 | Parvovirus B19 VP1, Recombinant | 1 mg |
| 1583 | 227-20187 | Parvovirus B19 VP1, Recombinant | 1 mg |
| 1584 | 227-20188 | Parvovirus B19 VP2, Recombinant | 1 mg |
| 1585 | 227-20189 | Troponin T-Cardiac, Recombinant | 1 mg |
| 1586 | 227-20190 | CENPB, Recombinant | 200 ug |
| 1587 | 227-20191 | LC-1, Recombinant | 200 ug |
| 1588 | 227-20192 | PCNA, Recombinant | 200 ug |
| 1589 | 227-20193 | Ro52, Recombinant | 200 ug |
| 1590 | 227-20194 | tTg, Recombinant | 200 ug |
| 1591 | 227-20195 | HBsAg (adr) Recombinant | 500 ug |
| 1592 | 227-20196 | Dengue Virus Type 1, NS1, Recombinant | 1 mg |
| 1593 | 227-20197 | Dengue Virus Type 2, NS1, Recombinant | 1 mg |
| 1594 | 227-20198 | Dengue Virus Type 3, NS1, Recombinant | 1 mg |
| 1595 | 227-20199 | Dengue Virus Type 1, EP, Recombinant | 1 mg |
| 1596 | 227-20200 | Dengue Virus Type 2, EP, Recombinant | 1 mg |
| 1597 | 227-20201 | Dengue Type 3 EP, Recombinant | 1 mg |
| 1598 | 227-20202 | Dengue Type 4 EP, Recombinant | 1 mg |
| 1599 | 227-20203 | Dengue Type 4 NS1, Recombinant | 1 mg |
| 1600 | 227-20204 | T. Pallidum TmpA, Recombinant | 1 mg |
| 1601 | 227-20205 | M. tuberculosis Chimera, Recombinant | 1 mg |
| 1602 | 227-20206 | B.BURGDORFERI Osp-C, Recombinant | 1 mg |
| 1603 | 227-20207 | Salmonella typhi OMP Recombinant | 1 mg |
| 1604 | 227-20208 | Trypanosoma cruzi B13, Recombinant | 1 mg |
| 1605 | 227-20209 | EBV EBNA-1, Recombinant | 1 mg |
| 1606 | 227-20210 | HSV-2 (gG-2) Recombinant | 1 mg |
| 1607 | 227-20211 | PROTEIN A, Recombinant | 10 mg |
| 1608 | 227-20212 | Human IL-18, Recombinant | 1 mg |
| 1609 | 227-20213 | CCL2, Recombinant | 25 ug |
| 1610 | 227-20214 | CCL17, Recombinant | 25 ug |
| 1611 | 227-20215 | IGF-2, Recombinant | 100 ug |
| 1612 | 227-20216 | T.pallidum p15/p17/p47, Recombinant | 1 mg |
| 1613 | 227-20217 | T.pallidum p15/p17/p47, Recombinant | 1 mg |
| 1614 | 227-20218 | Thyroid Peroxidase, Recombinant | 1 mg |
| 1615 | 227-20219 | Adenovirus Type 2 (Adenoid 6) Hexon | 1 mg |
| 1616 | 227-20220 | Echovirus 2 (Cornelis Strain) | 1 ml |
| 1617 | 227-20221 | Echovirus 11 (Gregory Strain) | 1 ml |
| 1618 | 227-20222 | Coxsackie A16 (G10 Strain) | 1 ml |
| 1619 | 227-20223 | HAV P2C-P3A Recombinant | 1 mg |
| 1620 | 227-20224 | SARS-CoV, Nucl. (1-49) Recombinant | 1 mg |
| 1621 | 227-20225 | VZV Ag, ORF9 (Dumas) Recombinant | 1 mg |
| 1622 | 227-20226 | VZV Ag, ORF26 (Dumas) Recombinant | 1 mg |
| 1623 | 227-20227 | GST CONTROL AG (HCVNS3) | 1 mg |
| 1624 | 227-20228 | SARS-CoV, Spike (N-term) Recombinant | 1 mg |
| 1625 | 227-20230 | Influenza A H5N1 NS1 | 50 ug |
| 1626 | 227-20231 | Influenza A H5N1 Hemagglutinin | 50 ug |
| 1627 | 227-20232 | Influenza A H5N1 NS2 | 50 ug |
| 1628 | 227-20233 | Influenza A H5N1 Neuraminidase | 50 ug |
| 1629 | 227-20234 | Influenza A H5N1 Hemagglutinin | 50 ug |
| 1630 | 227-20235 | Influenza A H5N1 Hemagglutinin | 50 ug |
| 1631 | 227-20236 | T. pallidum p47 Recombinant | 100 ug |
| 1632 | 227-20237 | HCV NS-4a+b Ag Recombinant | 100 ug |
| 1633 | 227-20238 | HAMA Serum | 1 ml |
| 1634 | 228-10001-2 | Tyr-3/Trp- 5 Monooxygenase Activation Protein Beta, Human Recombinant | 25 ug |
| 1635 | 228-10001-3 | Tyr-3/Trp- 5 Monooxygenase Activation Protein Beta, Human Recombinant | 1 mg |
| 1636 | 228-10002-2 | 4-1BB Ligand, Human Recombinant, His Tag | 20 ug |
| 1637 | 228-10002-3 | 4-1BB Ligand, Human Recombinant, His Tag | 1 mg |
| 1638 | 228-10003-2 | 4-1BB Receptor, Human Recombinant | 20 ug |
| 1639 | 228-10003-3 | 4-1BB Receptor, Human Recombinant | 1 mg |
| 1640 | 228-10005-2 | Alpha 1 Antitrypsin, Human Recombinant | 25 ug |
| 1641 | 228-10005-3 | Alpha 1 Antitrypsin, Human Recombinant | 1 mg |
| 1642 | 228-10006-2 | Microglobulin Alpha-1 Protein Human | 100 ug |
| 1643 | 228-10006-3 | Microglobulin Alpha-1 Protein Human | 1 mg |
| 1644 | 228-10007-2 | Macroglobulin Alpha-2 Human | 1mg |
| 1645 | 228-10007-3 | Macroglobulin Alpha-2 Human | 10mg |
| 1646 | 228-10008-2 | Acyl-Coenzyme A Dehydrogenase 8, Human Recombinant | 20 ug |
| 1647 | 228-10008-3 | Acyl-Coenzyme A Dehydrogenase 8, Human Recombinant | 1 mg |
| 1648 | 228-10009-2 | Acetyl-Coenzyme A acetyltransferase 2, Human Recombinant | 20 ug |
| 1649 | 228-10009-3 | Acetyl-Coenzyme A acetyltransferase 2, Human Recombinant | 1 mg |
| 1650 | 228-10010-2 | Acid Phosphatase-1, Human Recombinant | 20 ug |
| 1651 | 228-10010-3 | Acid Phosphatase-1, Human Recombinant | 1 mg |
| 1652 | 228-10018-2 | Alpha-1 AntiChymotrypsin Human | 100 ug |
| 1653 | 228-10018-3 | Alpha-1 AntiChymotrypsin Human | 1 mg |
| 1654 | 228-10021-2 | Actin | 50 ug |
| 1655 | 228-10021-3 | Actin | 1 mg |
| 1656 | 228-10022-2 | Activin A, Human Recombinant | 10 ug |
| 1657 | 228-10022-3 | Activin A, Human Recombinant | 1 mg |
| 1658 | 228-10024-2 | Aminoacylase-1, Human Recombinant | 10 ug |
| 1659 | 228-10024-3 | Aminoacylase-1, Human Recombinant | 1 mg |
| 1660 | 228-10025-2 | A Disintegrin and Metalloproteinase Domain 10, Human Recombinant | 10 ug |
| 1661 | 228-10025-3 | A Disintegrin and Metalloproteinase Domain 10, Human Recombinant | 1 mg |
| 1662 | 228-10026-2 | A Disintegrin and Metalloproteinase Domain 12 S-Isoform, Human Recombinant | 10 ug |
| 1663 | 228-10026-3 | A Disintegrin and Metalloproteinase Domain 12 S-Isoform, Human Recombinant | 1 mg |
| 1664 | 228-10027-2 | Adenosine Deaminase tRNA-Specific 1, Human Recombinant | 10 ug |
| 1665 | 228-10027-3 | Adenosine Deaminase tRNA-Specific 1, Human Recombinant | 1 mg |
| 1666 | 228-10028-2 | Adipose Differentiation-Related Protein, Human Recombinant | 10 ug |
| 1667 | 228-10028-3 | Adipose Differentiation-Related Protein, Human Recombinant | 1 mg |
| 1668 | 228-10029-2 | Alpha-Fetoprotein Human | 2×25 ug |
| 1669 | 228-10029-3 | Alpha-Fetoprotein Human | 1 mg |
| 1670 | 228-10030-2 | Mycobacterium Tuberculosis major secretory protein Antigen 85B Recombinant | 10 ug |
| 1671 | 228-10030-3 | Mycobacterium Tuberculosis major secretory protein Antigen 85B Recombinant | 100 ug |
| 1672 | 228-10031-2 | Anterior Gradient Protein 2 Homolog, Human Recombinant | 20 ug |
| 1673 | 228-10031-3 | Anterior Gradient Protein 2 Homolog, Human Recombinant | 1 mg |
| 1674 | 228-10032-2 | Agouti–Related Protein, Human Recombinant | 10 ug |
| 1675 | 228-10032-3 | Agouti–Related Protein, Human Recombinant | 1 mg |
| 1676 | 228-10033-2 | Activator of HSP90 ATPase-1, Human Recombinant | 50 ug |
| 1677 | 228-10033-3 | Activator of HSP90 ATPase-1, Human Recombinant | 1 mg |
| 1678 | 228-10034-2 | Alpha Hemoglobin Stabilizing Protein, Human Recombinant | 50 ug |
| 1679 | 228-10034-3 | Alpha Hemoglobin Stabilizing Protein, Human Recombinant | 1 mg |
| 1680 | 228-10036-2 | AITRL, Human Recombinant, His Tag | 20 ug |
| 1681 | 228-10036-3 | AITRL, Human Recombinant, His Tag | 1 mg |
| 1682 | 228-10037-2 | Adenylate Kinase 2, Human Recombinant | 10 ug |
| 1683 | 228-10037-3 | Adenylate Kinase 2, Human Recombinant | 1 mg |
| 1684 | 228-10038-2 | Adenylate Kinase-3 Like 1, Human Recombinant | 20 ug |
| 1685 | 228-10038-3 | Adenylate Kinase-3 Like 1, Human Recombinant | 1 mg |
| 1686 | 228-10039-2 | Aldose Reductase, Human Recombinant | 50 ug |
| 1687 | 228-10039-3 | Aldose Reductase, Human Recombinant | 1 mg |
| 1688 | 228-10040-2 | Aldo-Keto Reductase Family 1 Member B10, Human Recombinant | 20 ug |
| 1689 | 228-10040-3 | Aldo-Keto Reductase Family 1 Member B10, Human Recombinant | 1 mg |
| 1690 | 228-10041-2 | Aldo-Keto Reductase Family 1 Member C3, Human Recombinant | 20 ug |
| 1691 | 228-10041-3 | Aldo-Keto Reductase Family 1 Member C3, Human Recombinant | 1 mg |
| 1692 | 228-10043-2 | Glutamic-Pyruvate Transaminase, Human Recombinant, Active | 3 U |
| 1693 | 228-10043-3 | Glutamic-Pyruvate Transaminase, Human Recombinant, Active | 50 U |
| 1694 | 228-10044-2 | Aldehyde Dehydrogenase, Human Recombinant | 50 ug |
| 1695 | 228-10044-3 | Aldehyde Dehydrogenase, Human Recombinant | 1 mg |
| 1696 | 228-10046-2 | Alkaline Phosphatase Bovine Intestinal | 5 mg |
| 1697 | 228-10046-3 | Alkaline Phosphatase Bovine Intestinal | 30 mg |
| 1698 | 228-10047-2 | Actinin Alpha | 50 ug |
| 1699 | 228-10047-3 | Actinin Alpha | 1 mg |
| 1700 | 228-10048-2 | Aminopeptidase Aeromonas Recombinant | 250 U |
| 1701 | 228-10048-3 | Aminopeptidase Aeromonas Recombinant | 500U |
| 1702 | 228-10051-2 | Angiostatin Kringles 1-3, Human Recombinant | 100 ug |
| 1703 | 228-10051-3 | Angiostatin Kringles 1-3, Human Recombinant | 1 mg |
| 1704 | 228-10052-2 | Angiostatin Kringles 1-4 Human | 10 ug |
| 1705 | 228-10052-3 | Angiostatin Kringles 1-4 Human | 1 mg |
| 1706 | 228-10054-2 | Angiopoietin Like Protein 3, Human Recombinant | 10 ug |
| 1707 | 228-10054-3 | Angiopoietin Like Protein 3, Human Recombinant | 1 mg |
| 1708 | 228-10055-2 | Angiopoietin-like Protein 4, Human Recombinant | 10 ug |
| 1709 | 228-10055-3 | Angiopoietin-like Protein 4, Human Recombinant | 1 mg |
| 1710 | 228-10057-2 | Annexin A1, Human Recombinant | 10 ug |
| 1711 | 228-10057-3 | Annexin A1, Human Recombinant | 100 ug |
| 1712 | 228-10058-2 | Annexin A7, Human Recombinant | 20 ug |
| 1713 | 228-10058-3 | Annexin A7, Human Recombinant | 1 mg |
| 1714 | 228-10060-2 | Receptor Associated Protein, Rat Recombinant | 20 ug |
| 1715 | 228-10060-3 | Receptor Associated Protein, Rat Recombinant | 1 mg |
| 1716 | 228-10065-2 | Autophagy Related 5, Human Recombinant | 10 ug |
| 1717 | 228-10066-2 | Apolipoprotein-D, Human Recombinant | 10 ug |
| 1718 | 228-10066-3 | Apolipoprotein-D, Human Recombinant | 1 mg |
| 1719 | 228-10068-2 | Apo Transferrin Human | 1 gram |
| 1720 | 228-10068-3 | Apo Transferrin Human | 5 gram |
| 1721 | 228-10069-2 | Apo Transferrin Bovine | 150 mg |
| 1722 | 228-10069-3 | Apo Transferrin Bovine | 1 gram |
| 1723 | 228-10070-2 | Apolipoprotein A-I, Human Recombinant, His Tag | 100 ug |
| 1724 | 228-10070-3 | Apolipoprotein A-I, Human Recombinant, His Tag | 1 mg |
| 1725 | 228-10071-2 | Aprotinin | 250 mg |
| 1726 | 228-10071-3 | Aprotinin | 1 gram |
| 1727 | 228-10076-2 | Alpha Synuclein, Human Recombinant | 100 ug |
| 1728 | 228-10076-3 | Alpha Synuclein, Human Recombinant | 1 mg |
| 1729 | 228-10080-2 | Ataxin-3, Human Recombinant | 10 ug |
| 1730 | 228-10080-3 | Ataxin-3, Human Recombinant | 1 mg |
| 1731 | 228-10081-2 | Aurora Kinase A, Human Recombinant | 10 ug |
| 1732 | 228-10081-3 | Aurora Kinase A, Human Recombinant | 1 mg |
| 1733 | 228-10082-2 | Avidin | 25 mg |
| 1734 | 228-10082-3 | Avidin | 100 mg |
| 1735 | 228-10083-2 | Modified Affinity Purified Avidin | 10 mg |
| 1736 | 228-10083-3 | Modified Affinity Purified Avidin | 100 mg |
| 1737 | 228-10084-2 | Apolipoprotein-H Human | 1 mg |
| 1738 | 228-10084-3 | Apolipoprotein-H Human | 5 mg |
| 1739 | 228-10085-2 | Apolipoprotein-H, Human Recombinant, Sf9 | 20 ug |
| 1740 | 228-10085-3 | Apolipoprotein-H, Human Recombinant, Sf9 | 1 mg |
| 1741 | 228-10086-2 | Beta-2 Microglobulin Human | 1 mg |
| 1742 | 228-10086-3 | Beta-2 Microglobulin Human | 10 mg |
| 1743 | 228-10091-2 | B cell Activating Factor, Human Recombinant, His Tag | 20 ug |
| 1744 | 228-10091-3 | B cell Activating Factor, Human Recombinant, His Tag | 1 mg |
| 1745 | 228-10092-2 | B-cell Activating Factor Receptor, Human Recombinant | 50 ug |
| 1746 | 228-10092-3 | B-cell Activating Factor Receptor, Human Recombinant | 1 mg |
| 1747 | 228-10094-2 | Bax, Mouse Recombinant | 10 ug |
| 1748 | 228-10094-3 | Bax, Mouse Recombinant | 1 mg |
| 1749 | 228-10096-2 | BCA-1/BLC, Human Recombinant (CXCL13) | 20 ug |
| 1750 | 228-10096-3 | BCA-1/BLC, Human Recombinant (CXCL13) | 1 mg |
| 1751 | 228-10097-2 | B-Cell Leukemia/Lymphoma 2, (1-206 a.a.), Human Recombinant | 10 ug |
| 1752 | 228-10097-3 | B-Cell Leukemia/Lymphoma 2, (1-206 a.a.), Human Recombinant | 1 mg |
| 1753 | 228-10099-2 | B-Cell Leukemia/Lymphoma 2, Human Recombinant (–BH2) | 10 ug |
| 1754 | 228-10099-3 | B-Cell Leukemia/Lymphoma 2, Human Recombinant (–BH2) | 1 mg |
| 1755 | 228-10100-2 | B-Cell Leukemia/Lymphoma 2, Human Recombinant (–BH3) | 10 ug |
| 1756 | 228-10100-3 | B-Cell Leukemia/Lymphoma 2, Human Recombinant (–BH3) | 1 mg |
| 1757 | 228-10101-2 | B-Cell Leukemia/Lymphoma 2, Human Recombinant (-BH4) | 10 ug |
| 1758 | 228-10101-3 | B-Cell Leukemia/Lymphoma 2, Human Recombinant (-BH4) | 1 mg |
| 1759 | 228-10102-2 | B-Cell Lymphoma Protein 2 Alpha, Human Recombinant, His Tag | 20 ug |
| 1760 | 228-10102-3 | B-Cell Lymphoma Protein 2 Alpha, Human Recombinant, His Tag | 1 mg |
| 1761 | 228-10103-2 | B-Cell Leukemia/Lymphoma 2, Human Recombinant (–NWGR) | 10 ug |
| 1762 | 228-10103-3 | B-Cell Leukemia/Lymphoma 2, Human Recombinant (–NWGR) | 1 mg |
| 1763 | 228-10105-2 | B-Cell Lymphoma Extra Large, Human Recombinant | 50 ug |
| 1764 | 228-10105-3 | B-Cell Lymphoma Extra Large, Human Recombinant | 1 mg |
| 1765 | 228-10107-2 | B-Cell Lymphoma Extra Large, Human Recombinant, His Tag | 10 ug |
| 1766 | 228-10107-3 | B-Cell Lymphoma Extra Large, Human Recombinant, His Tag | 1 mg |
| 1767 | 228-10108-2 | Beta Defensin-1, Human Recombinant | 20 ug |
| 1768 | 228-10108-3 | Beta Defensin-1, Human Recombinant | 1 mg |
| 1769 | 228-10109-2 | Beta Defensin-2, Human Recombinant | 20 ug |
| 1770 | 228-10109-3 | Beta Defensin-2, Human Recombinant | 1 mg |
| 1771 | 228-10110-2 | Beta Defensin-3, Human Recombinant | 20 ug |
| 1772 | 228-10110-3 | Beta Defensin-3, Human Recombinant | 1 mg |
| 1773 | 228-10111-2 | Beta Defensin-4, Human Recombinant | 20 ug |
| 1774 | 228-10111-3 | Beta Defensin-4, Human Recombinant | 1 mg |
| 1775 | 228-10113-2 | Beta-Nerve Growth Factor Mouse | 20 ug |
| 1776 | 228-10113-3 | Beta-Nerve Growth Factor Mouse | 1 mg |
| 1777 | 228-10114-2 | Beta Nerve Growth Factor, Mouse Recombinant | 20 ug |
| 1778 | 228-10114-3 | Beta Nerve Growth Factor, Mouse Recombinant | 1 mg |
| 1779 | 228-10115-2 | Beta Nerve Growth Factor, Human Recombinant | 20µg |
| 1780 | 228-10115-3 | Beta Nerve Growth Factor, Human Recombinant | 1 mg |
| 1781 | 228-10116-2 | Beta-Nerve Growth Factor, Human Recombinant, CHO | 20 ug |
| 1782 | 228-10116-3 | Beta-Nerve Growth Factor, Human Recombinant, CHO | 1 mg |
| 1783 | 228-10117-2 | Beta-Synuclein, Human Recombinant | 50 ug |
| 1784 | 228-10117-3 | Beta-Synuclein, Human Recombinant | 1 mg |
| 1785 | 228-10119-2 | Betaine Homocysteine S-Methyltransferase, Human Recombinant | 50 ug |
| 1786 | 228-10119-3 | Betaine Homocysteine S-Methyltransferase, Human Recombinant | 1 mg |
| 1787 | 228-10120-2 | BH3 Interacting Domain Death Agonist, Human Recombinant | 10 ug |
| 1788 | 228-10120-3 | BH3 Interacting Domain Death Agonist, Human Recombinant | 1 mg |
| 1789 | 228-10121-2 | BH3 Interacting Domain Death Agonist, Mouse Recombinant | 10 ug |
| 1790 | 228-10121-3 | BH3 Interacting Domain Death Agonist, Mouse Recombinant | 1 mg |
| 1791 | 228-10123-2 | Baculoviral IAP Repeat-Containing 5, Human Recombinant | 25 ug |
| 1792 | 228-10123-3 | Baculoviral IAP Repeat-Containing 5, Human Recombinant | 1 mg |
| 1793 | 228-10124-2 | Baculoviral IAP Repeat-Containing 7, Human Recombinant | 20 ug |
| 1794 | 228-10124-3 | Baculoviral IAP Repeat-Containing 7, Human Recombinant | 1 mg |
| 1795 | 228-10125-2 | Bivalirudin | 5 mg |
| 1796 | 228-10125-3 | Bivalirudin | 100 mg |
| 1797 | 228-10126-2 | Biliverdin Reductase B, Human Recombinant | 50 ug |
| 1798 | 228-10126-3 | Biliverdin Reductase B, Human Recombinant | 1 mg |
| 1799 | 228-10127-2 | Bcl2 Modifying Factor, Isoform 3, Human Recombinant | 20 ug |
| 1800 | 228-10127-3 | Bcl2 Modifying Factor, Isoform 3, Human Recombinant | 1 mg |
| 1801 | 228-10128-2 | Bone Morphogenetic Protein-2, Human Recombinant | 10 ug |
| 1802 | 228-10128-3 | Bone Morphogenetic Protein-2, Human Recombinant | 1 mg |
| 1803 | 228-10130-2 | Bone Morphogenetic Protein-2, Human Recombinant, Monomer | 20 ug |
| 1804 | 228-10130-3 | Bone Morphogenetic Protein-2, Human Recombinant, Monomer | 1 mg |
| 1805 | 228-10131-2 | Bone Morphogenetic Protein-4, Human Recombinant | 10 ug |
| 1806 | 228-10131-3 | Bone Morphogenetic Protein-4, Human Recombinant | 1 mg |
| 1807 | 228-10132-2 | Bone Morphogenetic protein-5, Human Recombinant | 20 ug |
| 1808 | 228-10132-3 | Bone Morphogenetic protein-5, Human Recombinant | 1 mg |
| 1809 | 228-10134-2 | Bone Morphogenetic Protein-7, Human Recombinant | 10 ug |
| 1810 | 228-10134-3 | Bone Morphogenetic Protein-7, Human Recombinant | 1 mg |
| 1811 | 228-10135-2 | Bone Morphogenetic Protein-7, Human Recombinant, CHO | 10 ug |
| 1812 | 228-10135-3 | Bone Morphogenetic Protein-7, Human Recombinant, CHO | 1 mg |
| 1813 | 228-10136-2 | Bone Morphogenetic Protein-7, Human Recombinant, His Tag | 50 ug |
| 1814 | 228-10136-3 | Bone Morphogenetic Protein-7, Human Recombinant, His Tag | 1 mg |
| 1815 | 228-10137-2 | Bone Morphogenetic Protein Receptor Type IA, Human Recombinant | 10 ug |
| 1816 | 228-10137-3 | Bone Morphogenetic Protein Receptor Type IA, Human Recombinant | 1 mg |
| 1817 | 228-10139-2 | B-type Natriuretic Peptide, Human Recombinant | 10 ug |
| 1818 | 228-10139-3 | B-type Natriuretic Peptide, Human Recombinant | 1 mg |
| 1819 | 228-10140-2 | B-type Natriuretic Peptide, Human Recombinant, His Tag | 10 ug |
| 1820 | 228-10140-3 | B-type Natriuretic Peptide, Human Recombinant, His Tag | 1 mg |
| 1821 | 228-10141-2 | Borrelia Burgdorferi p41 Recombinant | 500 ug |
| 1822 | 228-10141-3 | Borrelia Burgdorferi p41 Recombinant | 1000 ug |
| 1823 | 228-10143-2 | BRAK, Human Recombinant (CXCL14), His-Tag | 5µg |
| 1824 | 228-10143-3 | BRAK, Human Recombinant (CXCL14), His-Tag | 50µg |
| 1825 | 228-10144-2 | H3N2 Influenza-A Virus Brisbane 10/07 | 50 ug |
| 1826 | 228-10144-3 | H3N2 Influenza-A Virus Brisbane 10/07 | 1 mg |
| 1827 | 228-10145-2 | Bovine Serum Albumin | 50 gr |
| 1828 | 228-10145-3 | Bovine Serum Albumin | 100 gr |
| 1829 | 228-10146-2 | Betacellulin Bovine Recombinant | 20 ug |
| 1830 | 228-10146-3 | Betacellulin Bovine Recombinant | 1 mg |
| 1831 | 228-10149-2 | C-10, Mouse Recombinant (CCL6) | 10 ug |
| 1832 | 228-10149-3 | C-10, Mouse Recombinant (CCL6) | 1 mg |
| 1833 | 228-10150-2 | Complement Component 1, Human Recombinant | 25 ug |
| 1834 | 228-10150-3 | Complement Component 1, Human Recombinant | 1 mg |
| 1835 | 228-10151-2 | Complement C1q Tumor Necrosis Factor-Related Protein 1, Human Recombinant | 10 ug |
| 1836 | 228-10151-3 | Complement C1q Tumor Necrosis Factor-Related Protein 1, Human Recombinant | 1 mg |
| 1837 | 228-10152-2 | Complement C1q Tumor Necrosis Factor-Related Protein 3, Human Recombinant | 10 ug |
| 1838 | 228-10152-3 | Complement C1q Tumor Necrosis Factor-Related Protein 3, Human Recombinant | 1 mg |
| 1839 | 228-10153-2 | Complement C1q Tumor Necrosis Factor-Related Protein 6, Human Recombinant | 10 ug |
| 1840 | 228-10153-3 | Complement C1q Tumor Necrosis Factor-Related Protein 6, Human Recombinant | 1 mg |
| 1841 | 228-10154-2 | Complement C1q Tumor Necrosis Factor-Related Protein 7, Human Recombinant | 10 ug |
| 1842 | 228-10154-3 | Complement C1q Tumor Necrosis Factor-Related Protein 7, Human Recombinant | 1 mg |
| 1843 | 228-10155-2 | Calbindin-1, Rat Recombinant | 5 ug |
| 1844 | 228-10155-3 | Calbindin-1, Rat Recombinant | 100 ug |
| 1845 | 228-10156-2 | Calbindin-2, Human Recombinant | 25 ug |
| 1846 | 228-10156-3 | Calbindin-2, Human Recombinant | 1 mg |
| 1847 | 228-10157-2 | S100 Calcium Binding Protein G, Rat Recombinant | 5 ug |
| 1848 | 228-10157-3 | S100 Calcium Binding Protein G, Rat Recombinant | 100 ug |
| 1849 | 228-10158-2 | Cadherin-E, Human Recombinant | 5 ug |
| 1850 | 228-10158-3 | Cadherin-E, Human Recombinant | 10 ug |
| 1851 | 228-10159-2 | Sirtuin 3, Human Recombinant | 10 ug |
| 1852 | 228-10159-3 | Sirtuin 3, Human Recombinant | 1 mg |
| 1853 | 228-10160-2 | Carbonic Anhydrase III, Human Recombinant, His Tag | 20 ug |
| 1854 | 228-10160-3 | Carbonic Anhydrase III, Human Recombinant, His Tag | 1 mg |
| 1855 | 228-10161-2 | Calbindin-2, Mouse Recombinant | 5 ug |
| 1856 | 228-10161-3 | Calbindin-2, Mouse Recombinant | 10 ug |
| 1857 | 228-10162-2 | Calcitonin Acetate Salmon | 5 mg |
| 1858 | 228-10162-3 | Calcitonin Acetate Salmon | 25 mg |
| 1859 | 228-10163-2 | H1N1 Influenza-A Virus New Caledonia/20/99 IVR 116 | 50 ug |
| 1860 | 228-10163-3 | H1N1 Influenza-A Virus New Caledonia/20/99 IVR 116 | 1 mg |
| 1861 | 228-10164-2 | H1N1 Influenza-A Virus New Caledonia/20/99 Recombinant | 10 ug |
| 1862 | 228-10164-3 | H1N1 Influenza-A Virus New Caledonia/20/99 Recombinant | 100 ug |
| 1863 | 228-10165-2 | Calmodulin-2, Human Recombinant | 25 ug |
| 1864 | 228-10165-3 | Calmodulin-2, Human Recombinant | 1 mg |
| 1865 | 228-10166-2 | Calmodulin-2 135 a.a., Human Recombinant | 50 ug |
| 1866 | 228-10166-3 | Calmodulin-2 135 a.a., Human Recombinant | 1 mg |
| 1867 | 228-10167-2 | Calsequestrin-2 Dog | 5 ug |
| 1868 | 228-10167-3 | Calsequestrin-2 Dog | 10 ug |
| 1869 | 228-10168-2 | Calumenin, Human Recombinant | 25 ug |
| 1870 | 228-10168-3 | Calumenin, Human Recombinant | 1 mg |
| 1871 | 228-10169-2 | Human Calpain-1 Catalytic Subunit | 5 ug |
| 1872 | 228-10169-3 | Human Calpain-1 Catalytic Subunit | 10 ug |
| 1873 | 228-10171-2 | Carbonic Anhydrase II E.coli Recombinant | 25 ug |
| 1874 | 228-10171-3 | Carbonic Anhydrase II E.coli Recombinant | 1 mg |
| 1875 | 228-10172-2 | Carbonic Anhydrase 2, Human Recombinant | 20 ug |
| 1876 | 228-10172-3 | Carbonic Anhydrase 2, Human Recombinant | 1 mg |
| 1877 | 228-10173-2 | Cardiac Actin | 10 ug |
| 1878 | 228-10173-3 | Cardiac Actin | 1 mg |
| 1879 | 228-10176-2 | Carbonyl Reductase-1, Human Recombinant | 20 ug |
| 1880 | 228-10176-3 | Carbonyl Reductase-1, Human Recombinant | 1 mg |
| 1881 | 228-10177-2 | Carbonyl Reductase-3, Human Recombinant | 20 ug |
| 1882 | 228-10177-3 | Carbonyl Reductase-3, Human Recombinant | 1 mg |
| 1883 | 228-10178-2 | LEC/NCC-4, Human Recombinant | 20 ug |
| 1884 | 228-10178-3 | LEC/NCC-4, Human Recombinant | 1 mg |
| 1885 | 228-10181-2 | CD14, Mouse Recombinant | 5 ug |
| 1886 | 228-10181-3 | CD14, Mouse Recombinant | 10 ug |
| 1887 | 228-10184-2 | CD14, Human Recombinant, CHO | 50 ug |
| 1888 | 228-10184-3 | CD14, Human Recombinant, CHO | 1 mg |
| 1889 | 228-10186-2 | CD2, Human Recombinant, GST Tag | 5 ug |
| 1890 | 228-10186-3 | CD2, Human Recombinant, GST Tag | 10 ug |
| 1891 | 228-10187-2 | CD23, Human Recombinant, GST Tag | 5 ug |
| 1892 | 228-10187-3 | CD23, Human Recombinant, GST Tag | 10 ug |
| 1893 | 228-10190-2 | CD34, Human Recombinant, GST Tag | 5 ug |
| 1894 | 228-10190-3 | CD34, Human Recombinant, GST Tag | 10 ug |
| 1895 | 228-10191-2 | Soluble CD4, Human Recombinant | 10 ug |
| 1896 | 228-10191-3 | Soluble CD4, Human Recombinant | 1 mg |
| 1897 | 228-10192-2 | CD-4 (125-202 a.a.), Human Recombinant | 20 ug |
| 1898 | 228-10192-3 | CD-4 (125-202 a.a.), Human Recombinant | 1 mg |
| 1899 | 228-10193-2 | CD-4 (203-317 a.a.), Human Recombinant | 20 ug |
| 1900 | 228-10193-3 | CD-4 (203-317 a.a.), Human Recombinant | 1 mg |
| 1901 | 228-10194-2 | CD-4 (26-226 a.a.), Human Recombinant | 5 ug |
| 1902 | 228-10194-3 | CD-4 (26-226 a.a.), Human Recombinant | 10 ug |
| 1903 | 228-10196-2 | Soluble CD-40 Ligand/TRAP, Human Recombinant | 50 ug |
| 1904 | 228-10196-3 | Soluble CD-40 Ligand/TRAP, Human Recombinant | 1 mg |
| 1905 | 228-10197-2 | Soluble CD-40 Ligand/TRAP, Mouse Recombinant | 25 ug |
| 1906 | 228-10197-3 | Soluble CD-40 Ligand/TRAP, Mouse Recombinant | 1 mg |
| 1907 | 228-10198-2 | soluble CD40 Ligand/TRAP, Human Recombinant, His Tag | 20 ug |
| 1908 | 228-10198-3 | soluble CD40 Ligand/TRAP, Human Recombinant, His Tag | 1 mg |
| 1909 | 228-10204-2 | CD72, Human Recombinant | 5 ug |
| 1910 | 228-10204-3 | CD72, Human Recombinant | 10 ug |
| 1911 | 228-10206-2 | CD95, Human Recombinant, His Tag | 20 ug |
| 1912 | 228-10206-3 | CD95, Human Recombinant, His Tag | 1 mg |
| 1913 | 228-10207-2 | CD99, Human Recombinant | 5 ug |
| 1914 | 228-10207-3 | CD99, Human Recombinant | 10 ug |
| 1915 | 228-10208-2 | Cell Division Cycle 34, Human Recombinant | 20 ug |
| 1916 | 228-10208-3 | Cell Division Cycle 34, Human Recombinant | 1 mg |
| 1917 | 228-10209-2 | Cell Division Cycle 37, Human Recombinant | 25 ug |
| 1918 | 228-10209-3 | Cell Division Cycle 37, Human Recombinant | 1 mg |
| 1919 | 228-10211-2 | Cyclin-Dependent Kinase 4, Human Recombinant | 10 ug |
| 1920 | 228-10211-3 | Cyclin-Dependent Kinase 4, Human Recombinant | 1 mg |
| 1921 | 228-10213-2 | Carcinoembryonic Antigen, Human Recombinant | 10 ug |
| 1922 | 228-10213-3 | Carcinoembryonic Antigen, Human Recombinant | 1 mg |
| 1923 | 228-10214-2 | CCAAT/enhancer binding protein CEBP Alpha, Human Recombinant | 50 ug |
| 1924 | 228-10214-3 | CCAAT/enhancer binding protein CEBP Alpha, Human Recombinant | 1 mg |
| 1925 | 228-10215-2 | CCAAT/enhancer binding protein C/EBP Gamma Recombinant Human | 50 ug |
| 1926 | 228-10215-3 | CCAAT/enhancer binding protein C/EBP Gamma Recombinant Human | 1 mg |
| 1927 | 228-10216-2 | Centromere Protein A, Human Recombinant | 20 ug |
| 1928 | 228-10216-3 | Centromere Protein A, Human Recombinant | 1 mg |
| 1929 | 228-10217-2 | Centromere Protein B, Human Recombinant | 20 ug |
| 1930 | 228-10217-3 | Centromere Protein B, Human Recombinant | 1 mg |
| 1931 | 228-10218-2 | c-erbB2 Protein, Human Recombinant | 5 ug |
| 1932 | 228-10218-3 | c-erbB2 Protein, Human Recombinant | 10 ug |
| 1933 | 228-10220-2 | Cofilin-1, Human Recombinant | 20 ug |
| 1934 | 228-10220-3 | Cofilin-1, Human Recombinant | 1 mg |
| 1935 | 228-10221-2 | Protein Kinase A regulatory subunit-1 alpha, Human Recombinant | 25 ug |
| 1936 | 228-10221-3 | Protein Kinase A regulatory subunit-1 alpha, Human Recombinant | 50 ug |
| 1937 | 228-10222-2 | Chromogranin-A, Human Recombinant | 20 ug |
| 1938 | 228-10222-3 | Chromogranin-A, Human Recombinant | 1 mg |
| 1939 | 228-10224-2 | Chromogranin-A, Human Recombinant, His Tag | 10 ug |
| 1940 | 228-10224-3 | Chromogranin-A, Human Recombinant, His Tag | 1 mg |
| 1941 | 228-10225-2 | Chimeric Chagas Multiantigen Recombinant | 15 ug |
| 1942 | 228-10225-3 | Chimeric Chagas Multiantigen Recombinant | 100 ug |
| 1943 | 228-10226-2 | Chlamydia Trachomatis W2 Recombinant | 500 ug |
| 1944 | 228-10226-3 | Chlamydia Trachomatis W2 Recombinant | 1000 ug |
| 1945 | 228-10227-2 | Chlamidia Trachomatis W3-W6 Recombinant | 500 ug |
| 1946 | 228-10227-3 | Chlamidia Trachomatis W3-W6 Recombinant | 1000 ug |
| 1947 | 228-10228-2 | Chlamydia Trachomatis W4 Recombinant | 500 ug |
| 1948 | 228-10228-3 | Chlamydia Trachomatis W4 Recombinant | 1000 ug |
| 1949 | 228-10229-2 | Chlamydia Trachomatis W4-W5 Recombinant | 500 ug |
| 1950 | 228-10229-3 | Chlamydia Trachomatis W4-W5 Recombinant | 1000 ug |
| 1951 | 228-10230-2 | Chlamydia Trachomatis W5 Recombinant | 500 ug |
| 1952 | 228-10230-3 | Chlamydia Trachomatis W5 Recombinant | 1000 ug |
| 1953 | 228-10231-2 | Chlamydia Trachomatis W5-W6 Recombinant | 500 ug |
| 1954 | 228-10231-3 | Chlamydia Trachomatis W5-W6 Recombinant | 1000 ug |
| 1955 | 228-10232-2 | Chlamydia Trachomatis HSP70 (549-660 a.a.) Recombinant | 500 ug |
| 1956 | 228-10232-3 | Chlamydia Trachomatis HSP70 (549-660 a.a.) Recombinant | 1000 ug |
| 1957 | 228-10233-2 | Chlamydia Trachomatis HSP70 (462-503 a.a.) Recombinant | 500 ug |
| 1958 | 228-10233-3 | Chlamydia Trachomatis HSP70 (462-503 a.a.) Recombinant | 1000 ug |
| 1959 | 228-10234-2 | Chlamidia Trachomatis PGP-3D Recombinant | 500 ug |
| 1960 | 228-10234-3 | Chlamidia Trachomatis PGP-3D Recombinant | 1000 ug |
| 1961 | 228-10236-2 | Microtubule-Associated Protein Tau, Human Recombinant | 10 ug |
| 1962 | 228-10236-3 | Microtubule-Associated Protein Tau, Human Recombinant | 1 mg |
| 1963 | 228-10237-2 | Cbp/p300-Interacting Transactivator 2, Human Recombinant | 20 ug |
| 1964 | 228-10237-3 | Cbp/p300-Interacting Transactivator 2, Human Recombinant | 1 mg |
| 1965 | 228-10238-2 | Jun Proto-Oncogene, Human Recombinant | 10 ug |
| 1966 | 228-10238-3 | Jun Proto-Oncogene, Human Recombinant | 1 mg |
| 1967 | 228-10239-2 | Casein Kinase 2 Beta, Human Recombinant | 10 ug |
| 1968 | 228-10239-3 | Casein Kinase 2 Beta, Human Recombinant | 1 mg |
| 1969 | 228-10241-2 | Casein Kinase 2 Holoenzyme, Human Recombinant | 10 ug |
| 1970 | 228-10241-3 | Casein Kinase 2 Holoenzyme, Human Recombinant | 20 ug |
| 1971 | 228-10245-2 | Creatine Kinase Muscle Human | 1 mg |
| 1972 | 228-10245-3 | Creatine Kinase Muscle Human | 10 mg |
| 1973 | 228-10248-2 | CDC28 Protein Kinase 2, Human Recombinant | 25 ug |
| 1974 | 228-10248-3 | CDC28 Protein Kinase 2, Human Recombinant | 1 mg |
| 1975 | 228-10249-2 | Clusterin, Rat Recombinant | 10 ug |
| 1976 | 228-10249-3 | Clusterin, Rat Recombinant | 1 mg |
| 1977 | 228-10250-2 | Human Clusterin | 10 ug |
| 1978 | 228-10250-3 | Human Clusterin | 1 mg |
| 1979 | 228-10251-2 | Clusterin, Human Recombinant | 10 ug |
| 1980 | 228-10251-3 | Clusterin, Human Recombinant | 1 mg |
| 1981 | 228-10252-2 | Galectin-7, Human Recombinant, His Tag | 20 ug |
| 1982 | 228-10252-3 | Galectin-7, Human Recombinant, His Tag | 1 mg |
| 1983 | 228-10255-2 | Cytomegalo Virus Pp150 (UL32) Recombinant | 500 ug |
| 1984 | 228-10255-3 | Cytomegalo Virus Pp150 (UL32) Recombinant | 1000 ug |
| 1985 | 228-10256-2 | Cytomegalo Virus Pp28 (UL99) Recombinant | 500 ug |
| 1986 | 228-10256-3 | Cytomegalo Virus Pp28 (UL99) Recombinant | 1000 ug |
| 1987 | 228-10260-2 | Ciliary-Neurotrophic Factor, Human Recombinant | 20 ug |
| 1988 | 228-10260-3 | Ciliary-Neurotrophic Factor, Human Recombinant | 1 mg |
| 1989 | 228-10261-2 | Ciliary Neurotrophic Factor, Rat Recombinant | 25 ug |
| 1990 | 228-10261-3 | Ciliary Neurotrophic Factor, Rat Recombinant | 1 mg |
| 1991 | 228-10262-2 | Ciliary Neurotrophic Factor, Human Recombinant, His Tag | 20 ug |
| 1992 | 228-10262-3 | Ciliary Neurotrophic Factor, Human Recombinant, His Tag | 1 mg |
| 1993 | 228-10263-2 | Collagen Type IV Alpha 3, Human Recombinant | 10 ug |
| 1994 | 228-10263-3 | Collagen Type IV Alpha 3, Human Recombinant | 1 mg |
| 1995 | 228-10268-2 | Complement Component C1q Human | 1 mg |
| 1996 | 228-10268-3 | Complement Component C1q Human | 10 mg |
| 1997 | 228-10269-2 | Complement Component C3c Human | 1 mg |
| 1998 | 228-10269-3 | Complement Component C3c Human | 10 mg |
| 1999 | 228-10270-2 | Complement Component C4c Human | 1 mg |
| 2000 | 228-10270-3 | Complement Component C4c Human | 10 mg |
